QBE Insurance (ASX:QBE) share price on watch following UK COVID-19 court ruling

The QBE Insurance Group Ltd (ASX:QBE) share price is on watch today after an unfavourable COVID-19 court ruling in the UK…

The QBE Insurance Group Ltd (ASX: QBE) share price is not climbing higher with the market today.

In morning trade the insurance giant's shares are trading flat at $9.28 following the release of an announcement.

digital stock graph against backdrop of world map and covid bugs

Image source: Getty Images

What did QBE announce?

This morning QBE provided an update on its UK operations and the impact that a ruling by the High Court of England and Wales will have on its business.

According to the release, the High Court of England and Wales has handed down its decision in the test case commenced by the UK Financial Conduct Authority (FCA) in June 2020.

This test case was undertaken to resolve legal issues concerning the interpretation of common business interruption policy wordings.

This includes some policy wordings of QBE's UK operations, in the context of whether those policy wordings respond to COVID-19 and related government mandated nationwide lockdowns.

The company advised that the Court ruled in favour of QBE with respect to two out of three of its notifiable disease policy wordings examined and in favour of insurers with respect to denial of access policy wordings.

However, the Court ruled in favour of the insured with respect to one of QBE's notifiable disease policy wordings. This means that some of QBE policyholders are entitled to claim an insurance payout for business losses suffered when the UK went into lockdown between March and June because of COVID-19.

QBE is considering its options to appeal that decision.

What is the damage?

QBE estimates that its UK business interruption claims exposure is around $170 million before allowing for recoveries under its catastrophe reinsurance protections.

However, it believes that catastrophe reinsurance will limit the net cost of business interruption claims in its UK insurance business to $70 million. This already formed part of the $335 million net cost of COVID-19 allowed for in its recent half year results.

The company advised that it has the opportunity to apply to the Court for permission to appeal some or all of the ruling, with a decision expected to be then made in October.

And while it acknowledges that the estimated gross cost to QBE could increase or decrease, the net cost is not expected to vary.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

Man in shirt and tie falls face first down stairs.
Record Lows

I think this ASX 200 stock looks like a bargain after hitting an all-time low: Here's why

The ASX shares fell another 8% on Tuesday.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »

Army man holding a drone while the army woman holds the remote control.
52-Week Lows

Can DroneShield shares rebound from fresh 52-week low, or is there more downside ahead?

Investors have fallen out of love with the counter-drone operator’s shares.

Read more »